High expression of B7-H3 prevented doxorubicin-induced cellular senescence and growth arrest of CRC cells in vivo through the AKT/TM4SF1/SIRT1 pathway, while the knockdown of B7-H3 had the opposite effect [63]. The gene discussed is AKT1; the disease is colorectal carcinoma.